3 years ago

Fluorescence‐guided surgery for high‐grade gliomas

Nikita Lakomkin, Constantinos G. Hadjipanayis


5‐aminolevulinic acid (5‐ALA) is a prodrug that results in the fluorescence of high‐grade gliomas relative to the surrounding brain parenchyma. 5‐ALA has been increasingly utilized in fluorescence‐guided surgery for these tumors, and its intraoperative use has been associated with a significantly improved extent of resection and progression‐free survival. This review outlines the growing body of evidence that has culminated in the recent Food and Drug Administration approval of 5‐ALA, as well as emerging applications for this agent.

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.